Mesylate dihydrate salts of 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)-ethyl)-6-chloro-1,3-dihydro-2(1h)-indol-2-one(=ziprasidone), its preparation and its use as dopamine d2 antagonist

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

• Filed April 10, 1997 and granted April 8, 2003. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended April 10, 2017.
• A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by April 10, 2019.
• We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.